Papua New Guinea

in page functions
Total population (2012)7,170,112
Birth cohort (2012)209,788
Surviving Infants (surviving to 1 year per year, 2012)200,351
Infant mortality rate (deaths < 1 year per 1000 births, 2012)44.99/1000
Child mortality rate (deaths < 5 years per 1000 births, 2012)58.27/1000
World Bank Index, IDA (2012)3.30
Gross Nation Income (per capita US$, 2010)1,300
Co-financing status (2012)Intermediate
No. of districts/territories (2009)89

Contact GAVI

For more info, contact GAVI country representative officer or email here

GAVI support for Papua New Guinea

Type of support

Approvals

2001-2016 (US$)
(31 Dec 2011)

Commitments

2001-2016 (US$)
(31 Dec 2011)

Disbursements

2001-2012 (US$)
(31 Dec 2011)

% Disbursed

(31 Dec 2011)
2006200720082009201020112012201320142015
Immunisation Services Support (ISS)$434,000$434,000$434,000100%
Penta (NVS)$6,309,693$8,491,193$5,448,59086%
Tetra DTP-Hib (NVS)$1,521,883$1,521,883$1,521,883100%
Vaccine Introduction Grant$200,000$200,000$200,000100%
Total$8,465,576$10,647,076$7,604,473

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the GAVI Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding (IRC Reviewed)

Download data for commitments & disbursements in XLS format

Papua New Guinea DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2010)56%
DTP3 - Official country estimates (2010)70%
M:F sex ratio at birth (2012)1.08%
% districts achieving > 80% DTP3 coverage (2010)8%
% districts achieving < 50% DTP3 coverage (2010)44%
MCV WHO/UNICEF estimates (2010)55%
Polio WHO/UNICEF estimates (2010)61%

Breakdown of support

CSO, HSS & ISS supportVaccine support
8% 92%
$634,000 $6,970,473

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Papua New Guinea

09 June 2011

Developing nations take increasing responsibility for immunisation

Developing nations are making increasing financial commitments to the cost of childhood immunisation, a key foundation for social and economic development, the GAVI Alliance said ahead of a pledging conference on 13 June. [Français] [Deutsch]

10 March 2011

Country co-financing: exceeding commitments

Co-financing of GAVI vaccines on the increase

Since 2008, the number of countries required to co-finance new and underused vaccines supplied by GAVI has nearly doubled from 26 to 47 in 2010.

10 April 2008

Delivering the promise: through new markets, new money and new partnerships for development - Julian Lob-Levyt, GAVI Alliance Executive Secretary

Speaking to a gathering of eminent international scientists, Dr Lob-Levyt describes the business model of the GAVI Alliance and its impact through partnership on shaping vaccine markets, stimulating new financial resources, raising immunisation coverage in the world’s poorest countries, and strengthening the capacity of health systems to sustain and build health gains.

close icon

modal window here